| HDL subfraction distribution and HDL function in untreated dyslipidemic patients M Harangi, A Szentpéteri, B Nádró, H Lőrincz, I Seres, D Páll, G Paragh undefined 1, 166-173, 2017 | 20 | 2017 |
| Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy B Nádró, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ... Journal of International Medical Research 49 (5), 03000605211012213, 2021 | 16 | 2021 |
| The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis B Nádró, L Juhász, A Szentpéteri, D Páll, G Paragh, M Harangi Orvosi Hetilap 159 (5), 168-175, 2018 | 12 | 2018 |
| Determination of serum progranulin in patients with untreated familial hypercholesterolemia B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, É Varga, D Páll, ... Biomedicines 10 (4), 771, 2022 | 7 | 2022 |
| Sphingosine 1-phosphate and apolipoprotein M levels and their correlations with inflammatory biomarkers in patients with untreated familial hypercholesterolemia L Juhász, H Lőrincz, A Szentpéteri, B Nádró, É Varga, G Paragh, ... International Journal of Molecular Sciences 23 (22), 14065, 2022 | 4 | 2022 |
| Diagnostic and prognostic roles of serum progranulin, a novel marker of the carbohydrate metabolism and inflammation B Nádró, F Sztanek, H Lőrincz, D Páll, G Paragh, M Harangi Orvosi Hetilap 160 (25), 973-979, 2019 | 2 | 2019 |
| Changes in HDL subfraction distribution and myeloperoxidase/paraoxonase-1 ratio in untreated dyslipidemic patients B Nadro, A Szentpeteri, H Lorincz, L Juhasz, I Seres, D Pall, G Paragh, ... Atherosclerosis 275, e168, 2018 | 2 | 2018 |
| Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary B Kovács, Á Németh, B Daróczy, Z Karányi, L Maroda, Á Diószegi, ... Frontiers in Cardiovascular Medicine 9, 1081986, 2023 | 1 | 2023 |
| P76 Carotid Artery Disease in Patients with Newly Diagnosed, Untreated Familial Hypercholesterolemia B Nádró, B Kovács, Á Diószegi, L Juhász, D Páll, G Paragh, M Harangi Artery Research 25 (Suppl 1), S119-S119, 2019 | 1 | 2019 |
| Are we there yet? AI on traditional blood tests efficiently detects common and rare diseases Á Németh, G Tóth, P Fülöp, G Paragh, B Nádró, Z Karányi, G Paragh Jr, ... | | 2024 |
| ESTIMATING THE PREVALENCE OF CHILDHOOD HYPERTENSION AND ITS CONCOMITANT METABOLIC ABNORMALITIES IN THE NORTHEASTERN REGION OF HUNGARY USING DATA MINING METHODS D Pall, B Kovacs, A Nemeth, B Daroczy, Z Karanyi, L Maroda, M Zrinyi, ... Journal of Hypertension 42 (Suppl 1), e99, 2024 | | 2024 |
| ASSESSMENT OF HYPERTENSIVE PATIENTS’COMPLEX METABOLIC STATUS IN THE NORTHEASTERN REGION OF HUNGARY USING DATA MINING METHODS B Kovacs, A Nemeth, B Daroczy, Z Karanyi, L Maroda, M Zrinyi, ... Journal of Hypertension 42 (Suppl 1), e3, 2024 | | 2024 |
| Elevated sphingosine 1-phosphate level in familial hypercholesterolemic patients L Juhász, H Lőrincz, A Szentpéteri, B Nádró, É Varga, G Paragh, ... Atherosclerosis 379, S118, 2023 | | 2023 |
| Beáta Kovács1, Ákos Németh1, Bálint Daróczy2, 3, Zsolt Karányi1, László Maroda4, Ágnes Diószegi1, Bíborka Nádró1, Tamás Szabó5, Mariann Harangi1 and Dénes Páll4 B Kovács, Á Németh, B Daróczy, Z Karányi, L Maroda, Á Diószegi, ... Blood pressure in children and adolescents: Moving forward, 80, 2023 | | 2023 |
| Serum progranulin level in patients with newly diagnosed untreated familial hypercholesterolemia B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, I Seres, D Páll, ... Atherosclerosis 355, 166, 2022 | | 2022 |
| Cardiovascular risk factors in newly diagnosed, untreated Hungarian patients with familial hypercholesterolemia L Juhász, B Nádró, N Zsíros, G Paragh, M Harangi Atherosclerosis 331, e181, 2021 | | 2021 |
| Characterization of dyslipidemic patients with apolipoprotein E 2/2 genotype B Nádró, L Juhász, M Jalil, I Balogh, G Paragh, M Harangi Atherosclerosis 331, e181, 2021 | | 2021 |
| Changes in serum progranulin level and inflammatory markers in diabetic neuropathy F Sztanek, B Nádró, E Zöld, H Lőrincz, A Szentpéteri, Á Molnár, D Páll, ... Atherosclerosis 315, e202-e203, 2020 | | 2020 |
| Alpha-lipoic acid treatment increases serum progranulin level in diabetic neuropathy B Nádró, F Sztanek, H Lőrincz, A Szentpéteri, Á Molnár, S Ildikó, D Páll, ... Atherosclerosis 315, e202, 2020 | | 2020 |
| Severely affected familial hypercholesterolaemia patients with double and triple heterozygous mutations of candidate genes L Juhász, L Madar, I Balogh, B Kovács, B Nádró, G Paragh, H Mariann Atherosclerosis 315, e164-e165, 2020 | | 2020 |
Mariann HarangiUniversity of Debrecen Faculty of Medicine在 belklinika.com 的电子邮件经过验证
